Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 87

  • Quoted phrase not found.
1.

Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.

Dodge JC, Treleaven CM, Pacheco J, Cooper S, Bao C, Abraham M, Cromwell M, Sardi SP, Chuang WL, Sidman RL, Cheng SH, Shihabuddin LS.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8100-5. doi: 10.1073/pnas.1508767112. Epub 2015 Jun 8.

2.

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.

Kioumourtzoglou MA, Rotem RS, Seals RM, Gredal O, Hansen J, Weisskopf MG.

JAMA Neurol. 2015 Aug;72(8):905-11. doi: 10.1001/jamaneurol.2015.0910.

PMID:
26030836
3.

Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis.

Paganoni S, Hyman T, Shui A, Allred P, Harms M, Liu J, Maragakis N, Schoenfeld D, Yu H, Atassi N, Cudkowicz M, Miller TM.

Muscle Nerve. 2015 Sep;52(3):339-43. doi: 10.1002/mus.24688. Epub 2015 Jun 1.

PMID:
25900666
4.

Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.

Halbach MV, Stehning T, Damrath E, Jendrach M, Şen NE, Başak AN, Auburger G.

PLoS One. 2015 Mar 19;10(3):e0121089. doi: 10.1371/journal.pone.0121089. eCollection 2015.

5.

Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?

Nicholson KA, Cudkowicz ME, Berry JD.

Neurotherapeutics. 2015 Apr;12(2):376-83. doi: 10.1007/s13311-015-0341-2. Review.

6.

Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?

Dohrn MF, Othman A, Hirshman SK, Bode H, Alecu I, Fähndrich E, Karges W, Weis J, Schulz JB, Hornemann T, Claeys KG.

Eur J Neurol. 2015 May;22(5):806-14, e55. doi: 10.1111/ene.12663. Epub 2015 Jan 26.

PMID:
25623782
7.

Amyotrophic lateral sclerosis and agricultural environments: a systematic review.

Kang H, Cha ES, Choi GJ, Lee WJ.

J Korean Med Sci. 2014 Dec;29(12):1610-7. doi: 10.3346/jkms.2014.29.12.1610. Epub 2014 Nov 21. Review.

8.

Functional complementation in Drosophila to predict the pathogenicity of TARDBP variants: evidence for a loss-of-function mechanism.

Vanden Broeck L, Kleinberger G, Chapuis J, Gistelinck M, Amouyel P, Van Broeckhoven C, Lambert JC, Callaerts P, Dermaut B.

Neurobiol Aging. 2015 Feb;36(2):1121-9. doi: 10.1016/j.neurobiolaging.2014.09.001. Epub 2014 Sep 28.

PMID:
25442115
9.

Space-time distribution of the ALS incident cases by onset type in the Health District of Ferrara, Italy.

Govoni V, Della Coletta E, Cesnik E, Casetta I, Tugnoli V, Granieri E.

Acta Neurol Scand. 2015 Apr;131(4):246-52. doi: 10.1111/ane.12316. Epub 2014 Oct 14.

PMID:
25312935
10.

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.

Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TD, Palace J, Anthony DC, Sibson NR.

Neurology. 2014 Oct 21;83(17):1492-9. doi: 10.1212/WNL.0000000000000905. Epub 2014 Sep 24.

11.

Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.

Li MD, Burns TC, Morgan AA, Khatri P.

Acta Neuropathol Commun. 2014 Sep 4;2:93. doi: 10.1186/s40478-014-0093-y.

12.

Role of calpain-1 in the early phase of experimental ALS.

Stifanese R, Averna M, De Tullio R, Pedrazzi M, Milanese M, Bonifacino T, Bonanno G, Salamino F, Pontremoli S, Melloni E.

Arch Biochem Biophys. 2014 Nov 15;562:1-8. doi: 10.1016/j.abb.2014.08.006. Epub 2014 Aug 21.

PMID:
25151305
13.

ALS-associated peripherin spliced transcripts form distinct protein inclusions that are neuroprotective against oxidative stress.

McLean JR, Smith GA, Rocha EM, Osborn TM, Dib S, Hayes MA, Beagan JA, Brown TB, Lawson TF, Hallett PJ, Robertson J, Isacson O.

Exp Neurol. 2014 Nov;261:217-29. doi: 10.1016/j.expneurol.2014.05.024. Epub 2014 Jun 4.

PMID:
24907400
14.

Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.

Kent L, Vizard TN, Smith BN, Topp SD, Vance C, Gkazi A, Miller J, Shaw CE, Talbot K.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):557-62. doi: 10.3109/21678421.2014.920033. Epub 2014 Jun 5.

PMID:
24899262
15.

Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.

Oh SI, Park A, Kim HJ, Oh KW, Choi H, Kwon MJ, Ki CS, Kim HT, Kim SH.

PLoS One. 2014 Feb 3;9(2):e87163. doi: 10.1371/journal.pone.0087163. eCollection 2014.

16.

Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis.

Fekete T, Zach N, Mujica-Parodi LR, Turner MR.

PLoS One. 2013 Dec 31;8(12):e85190. doi: 10.1371/journal.pone.0085190. eCollection 2013.

17.

Association analysis of a functional variant in ATXN2 with schizophrenia.

Zhang F, Wang G, Shugart YY, Xu Y, Liu C, Wang L, Lu T, Yan H, Ruan Y, Cheng Z, Tian L, Jin C, Yuan J, Wang Z, Zhu W, Cao L, Liu Y, Yue W, Zhang D.

Neurosci Lett. 2014 Mar 6;562:24-7. doi: 10.1016/j.neulet.2013.12.001. Epub 2013 Dec 9.

PMID:
24333172
18.

Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations.

Shi Y, Rhodes NR, Abdolvahabi A, Kohn T, Cook NP, Marti AA, Shaw BF.

J Am Chem Soc. 2013 Oct 23;135(42):15897-908. doi: 10.1021/ja407801x. Epub 2013 Oct 10.

PMID:
24066782
19.

Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.

Hölscher C.

J Endocrinol. 2014 Mar 7;221(1):T31-41. doi: 10.1530/JOE-13-0221. Print 2014 Apr. Review.

20.

Effect of metal loading and subcellular pH on net charge of superoxide dismutase-1.

Shi Y, Mowery RA, Shaw BF.

J Mol Biol. 2013 Nov 15;425(22):4388-404. doi: 10.1016/j.jmb.2013.07.018. Epub 2013 Jul 17.

PMID:
23871896
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk